logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

Ascentage Pharma’s Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia

May 4, 2020

Life Science

医疗保健精选——吉利德科学2020年第一财季收益预览,FDA批准葛兰素史克Zejula的扩展适应症

Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula 

Apr 30, 2020

Life Science

医疗保健精选——罗氏entrectinib在加拿大获批;Sarepta制定COVID-19计划,盘前股价上涨5%

Healthcare Roundup – Roche’s entrectinib OK’d in Canada, Sarepta up 5% premarket on COVID-19 plan

Apr 28, 2020

Life Science

中国原创!绿谷阿尔兹海默症新药GV-971获批在美国展开临床试验

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s International, Phase III Clinical Study

Apr 27, 2020

Life Science

医疗保健精选——FDA批准Immunomedics抗体-药物偶联物治疗乳腺癌,辉瑞和BioNTech展开COVID-19疫苗研究

Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study

Apr 23, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID‐19 Related Delays

Apr 22, 2020

Life Science

全球两大联盟CEPI和Gavi称,必须全球统筹疫苗研发生产

World Must Work Together to Make Covid-19 Vaccine, CEPI, Gavi Say

Apr 17, 2020

Life Science

中国武汉启动血清流行病学调查,了解新冠肺炎无症状感染者情况

Wuhan Starts Survey to Examine Immunity Against Covid-19

Apr 15, 2020

Life Science

医疗保健综述–由于COVID-19,Teladoc服务在第一季度激增,Sonnet BioTherapeutics增长87%

Healthcare Roundup – Teladoc services surged in Q1 due to COVID-19, Sonnet BioTherapeutics up 87%

Apr 14, 2020

Life Science

美国有望夏天前恢复正常生活,辉瑞筛选出新冠肺炎候选药物

Healthcare Roundup –Fauci hopes to see steps to normalization by summer, Pfizer identifies lead COVID-19 candidate

Apr 9, 2020

Life Science

Zai Lab再鼎医药

Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)

Apr 8, 2020

Life Science

迈兰 疟疾 呼吸机 通用 羟化氯喹硫酸盐

Healthcare Roundup – Mylan to donate 10M doses of malaria drug, Feds award $489M ventilator contract to GM  

Apr 8, 2020

Life Science

康宁杰瑞 辉瑞 KN026

Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib)

Mar 30, 2020

Life Science

世卫组织:正在研制至少20种新冠病毒疫苗,确保人人接种

WHO officials say at least 20 coronavirus vaccines are in development in global race for cure

Mar 20, 2020

Life Science

梯瓦制药 冠状病毒 疟疾药物,意大利 疫情

Healthcare Roundup – Teva to donate 6M doses of malaria drug for coronavirus use, Italy now world’s #1 Covid-19 hotspot

Mar 20, 2020

Life Science

新冠病毒 中国 疫苗 试验

First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Months

Mar 19, 2020

Life Science

法维拉韦获治疗新冠病毒推荐,海正药业走红

Favilavir’s Covid-19 Effectiveness Boosts Hisun Pharma, Fujifilm Stock to Limit

Mar 19, 2020

Life Science

再鼎医药 则乐(尼拉帕利) 卵巢癌

(Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA

Mar 18, 2020

Life Science

  • ‹‹ Previous
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada